Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05024552
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2021-08-23
Brief Title:
Vyxeos Plus Gilteritinib in Relapsed or Refractory FLT3-Mutated AML
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-23
First Submit QC Date:
August 23 2021
Study First Post Date:
2021-08-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-27
Last Update Post Date:
2024-06-28
Last Update Post Date Type:
ACTUAL